Boston, MA, United States of America

Dong Yun Lee

This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignee: Scholar Rock, Inc.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dong Yun Lee. Retrieved from https://idiyas.com/inventor/dong-yun-lee-yjoecrm4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2019-2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Dong Yun Lee

Introduction

Dong Yun Lee is an accomplished inventor based in Boston, MA. He has made significant contributions to the field of biotechnology, particularly in the development of anti-Myostatin antibodies. With a total of three patents to his name, Lee's work has the potential to impact various therapeutic applications.

Latest Patents

Lee's latest patents include "Compositions for making and using anti-Myostatin antibodies" and "Methods for making and using anti-myostatin antibodies." These patents focus on antibodies that specifically bind proMyostatin and/or latent Myostatin, highlighting their uses in medical treatments and research.

Career Highlights

Throughout his career, Dong Yun Lee has demonstrated a commitment to advancing scientific knowledge and innovation. His work at Scholar Rock, Inc. has positioned him as a key player in the biotechnology sector, where he continues to explore new avenues for therapeutic development.

Collaborations

Lee collaborates with talented professionals in his field, including Michelle Marie Straub and William K McConaughy. These partnerships enhance the research and development efforts at Scholar Rock, Inc., fostering an environment of innovation.

Conclusion

Dong Yun Lee's contributions to biotechnology through his patents and collaborations underscore his role as a leading inventor in the field. His work on anti-Myostatin antibodies holds promise for future medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…